Dostarlimab immunotherapy has shown promising results in a small study of more than a dozen patients with rectal cancer, according to new research, but further research is needed and it is too early to call a cure. CNN’s Erin Burnett spoke with Dr. Andrea Chercek, an oncologist at Memorial Sloan Kettering Cancer Center.
Source: CNN
Add Comment